Laws and sections by number or title, due dates, pages, and updates.
The Employees State Insurance Corporation deletes item code NLEM263 from the approved item list of DGESIC RC-164. The affected drug is Nicotine Tab from approved firm Zim Laboratories Limited. This change applies to the rate contract effective from 08.04.2025 to 07.04.2027. Regional directors, deans, medical superintendents, and state directors take note of the deletion for necessary action.
What you must do
Key dates
Who is affected
Ask about this circular
[Image omitted. See the official document.]
U-25/12/RC/Amendment/Dosage/Misc/2025-MedV (E-1237671)/417
सेवा में,
Director (Medical) Delhi/Director (Medical) NOIDA Dean, All ESIC PGIMSR's, Medical & Dental Colleges Medical Superintendents-All ESIC Hospitals Director, ESI Scheme-All States
शुद्धिपत्र / Corrigendum -2025
Sub: Corrigendum in r/o Deletion of Item Code NLEM263 in DGESIC RC 164-reg.
Ref: No. U-25/12/RC/159TO163/2022-MedV(E-117064)/164 dt.08.04.2025 for DGESIC RC-164 effectives from 08.04.2025 to 07.04.2027.
Sir/Madam,
Reference captioned subject, it is hereby informed that below mention drug/item have been deleted from the approved item list of DGESIC RC-164 (effective wef 08.04.2025 to 07.04.2027).
| Name of the Approved Firm (M/s.) | RC No. Item No. Pref. in RC | Item Name/ Description |
|---|---|---|
| Zim Laboratories Limited | 164 NLEM263 L-1 | Nicotine Tab - Each Chewable tab to contain: Nicotine 2mg |
This is for your information and necessary action.
यह पत्र महानिदेशक, क.रा.बी.निगम के अनुमोदन से जारी किया जाता है।
शुभेषु Digitally signed by Sanjiv Kochhar Date: 01-08-2025 उप-चिकित्सा आयुक्त (चिकित्सा संविदा)
Copy for information to:
